(Q48446728)

11 February 2018

review article

1 reference

title

Off-label reports of new biologics: exciting new therapy or dubious research? Examples from recombinant activated factor VII. (English)

1 reference

11 February 2018

author name string

Walter H Dzik

series ordinal

1

1 reference

11 February 2018

publication date

1 January 2006

1 reference

11 February 2018

Journal of Intensive Care Medicine

published in

1 reference

11 February 2018

volume

21

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

54-59

1 reference

11 February 2018

Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0885066605285223

Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605285223

Use of recombinant activated factor VII (Novoseven) in trauma and surgery: analysis of outcomes reported to an international registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605285223

Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605285223

Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605285223

Acyclic retinoid induces partial differentiation, down-regulates telomerase reverse transcriptase mRNA expression and telomerase activity, and induces apoptosis in human hepatoma-derived cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605285223

Recombinant activated factor VII for acute intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605285223

Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605285223

Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605285223

Nesiritide — Not Verified

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605285223

An information infrastructure for the pharmaceutical market

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605285223

Pfizer pleads guilty, but drug sales continue to soar

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605285223

21 January 2018

Identifiers

DOI

10.1177/0885066605285223

1 reference

11 February 2018

1 reference

11 February 2018